Biogen Inc at Cowen HealthCare Conference Transcript
Good morning and welcome once again to Cowen and Company's 40th Annual Health Care Conference. I'm Phil Nadeau, one of the biotech analysts here in Cowen, and it's my pleasure to moderate a fireside chat with Biogen, one of the bellwethers of the industry. We're happy to have with us today, Michel Vounatsos, the CEO; as well as Joe Mara from IR; and Jeff Capello, the CFO, here in the front row.
Questions & Answers
Michel, maybe you can start with just giving us your vision for Biogen over the next 5 years. How is the company going to create shareholder value? And what will differentiate it as investment versus the other large caps?
So good morning, everyone. I'll be -- might be making some forward-looking statements or -- that contain risks and uncertainties, so I refer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
